| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |